lynntr59

MRNA LONG CALL

Long
NASDAQ:MRNA   Moderna, Inc.
MRNA has been consolidating and testing its resistance at 66.96, also it's hoping to begin a phase 3 trial in the coming weeks.
HUGE GAP UP can consider long call.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.